411 related articles for article (PubMed ID: 33664598)
1. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
[TBL] [Abstract][Full Text] [Related]
2. SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS.
Kiernan DF
Retin Cases Brief Rep; 2024 Jul; 18(4):421-427. PubMed ID: 36657153
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
Lima-Fontes M; Leuzinger-Dias M; Barros-Pereira R; Fernandes V; Falcão M; Falcão-Reis F; Rocha-Sousa A; Alves-Faria P
Ophthalmol Ther; 2023 Feb; 12(1):377-388. PubMed ID: 36417092
[TBL] [Abstract][Full Text] [Related]
5. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema - two years results.
Chronopoulos A; Chronopoulos P; Hattenbach LO; Ashurov A; Schutz JS; Pfeiffer N; Korb C
Eur J Ophthalmol; 2022 Sep; ():11206721221124688. PubMed ID: 36062617
[TBL] [Abstract][Full Text] [Related]
7. Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.
Weber LF; Marx S; Auffarth GU; Scheuerle AF; Tandogan T; Mayer C; Khoramnia R
J Ophthalmic Inflamm Infect; 2019 Jan; 9(1):3. PubMed ID: 30694420
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
Landré C; Zourdani A; Gastaud P; Baillif S
J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN
Carneiro A; Meireles A; Castro Sousa JP; Teixeira C
Ther Adv Ophthalmol; 2020; 12():2515841420917768. PubMed ID: 32548568
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
[TBL] [Abstract][Full Text] [Related]
13. The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN
Panos GD; Arruti N; Patra S
Eur J Ophthalmol; 2021 Mar; 31(2):620-629. PubMed ID: 31906704
[TBL] [Abstract][Full Text] [Related]
14. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN
Syed YY
Drugs; 2017 Apr; 77(5):575-583. PubMed ID: 28283896
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
Studsgaard A; Clemmensen KØ; Nielsen MS
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
[TBL] [Abstract][Full Text] [Related]
16. Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME).
McCluskey JD; Kaufman PL; Wynne K; Lewis G
Int Med Case Rep J; 2019; 12():93-102. PubMed ID: 31114396
[No Abstract] [Full Text] [Related]
17. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
[TBL] [Abstract][Full Text] [Related]
18. Switching to intravitreal fluocinolone acetonide implant for refractory diabetic macular edema: 12- and 24-month results.
Chronopoulos A; Chronopoulos P; Ashurov A; Korb C; Pfeiffer N; Hattenbach LO
Eur J Ophthalmol; 2022 Jan; 32(1):443-449. PubMed ID: 33601897
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes.
Currie CJ; Holden SE; Berni E; Owens DR
Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143
[TBL] [Abstract][Full Text] [Related]
20. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]